VeriMomchymotrypsin est-il sûr pendant la grossesse ?
No harmonised CLP reproductive classification or SCCS/CIR safety assessment was found for chymotrypsin (CAS 9004-07-3), and I found no peer-reviewed reports of developmental or reproductive toxicity from topical exposure. Available regulatory records describe it as an enzyme/protease (use as food enzyme or laboratory reagent) and list respiratory/irritant hazards in some notifications (typical for enzymes) but not reproductive hazards. Sources: ECHA substance/registration pages and EFSA food-enzyme safety review; no CIR/SCCS or harmonised reproductive flags were identified.
Related ingredients
Frequently asked questions
- chymotrypsin est-il sûr pendant la grossesse ?
- No harmonised CLP reproductive classification or SCCS/CIR safety assessment was found for chymotrypsin (CAS 9004-07-3), and I found no peer-reviewed reports of developmental or reproductive toxicity from topical exposure. Available regulatory records describe it as an enzyme/protease (use as food enzyme or laboratory reagent) and list respiratory/irritant hazards in some notifications (typical for enzymes) but not reproductive hazards. Sources: ECHA substance/registration pages and EFSA food-enzyme safety review; no CIR/SCCS or harmonised reproductive flags were identified.
- chymotrypsin est-il sûr pendant l'allaitement ?
- No data indicate chymotrypsin is a breastmilk-borne developmental hazard or that topical cosmetic use leads to systemic levels affecting lactation or the nursing infant. Human milk contains endogenous protease inhibitors (including antichymotrypsin), and regulatory reviews (food-enzyme safety) do not report lactation/transfer concerns. Respiratory sensitisation is noted in safety data sheets but does not constitute reproductive/lactation hazard evidence.
- chymotrypsin est-il sûr pour la peau de bébé ?
- There is no evidence of infant-specific reproductive toxicity. As a protein enzyme, chymotrypsin is a large molecule with very limited dermal bioavailability for intact skin, so adult exposure score is 0; however, by your scoring rules infant skin exposure is increased by +1 because baby skin has a less mature barrier and higher surface-area-to-weight, so baby e = 1. No studies show adverse developmental effects from topical cosmetic use in infants.
- Comment VeriMom évalue-t-il chymotrypsin ?
- VeriMom évalue chymotrypsin à 100/100 (pas de risques connus) sur la base du statut EU CosIng, des classifications ECHA et des études PubMed.
- Quelles sont les alternatives sûres à chymotrypsin pendant la grossesse ?
- Consultez notre liste d'alternatives sûres à chymotrypsin basée sur une fonction similaire et une classification sans risques connus.
Vérifiez chaque étiquette en 2 secondes
Obtenez VeriMom gratuitement — scannez n'importe quel produit et voyez le score de sécurité grossesse instantanément.
Avis Médical
Ces informations sont fournies à titre éducatif uniquement et ne constituent pas un avis médical. Les scores de sécurité sont basés sur des données accessibles au public et peuvent ne pas refléter tous les risques. Consultez toujours votre professionnel de santé avant d'utiliser tout produit pendant la grossesse ou l'allaitement.